The use of dopaminergic receptor stimulating agent (Pribedil, ET 495) in Parkinson's disease.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001058:Apomorphine / Q000627:therapeutic use; D004149:Dioxoles / Q000008:administration & dosage / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008875:Middle Aged; D009043:Motor Activity; D010300:Parkinson Disease / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000978:Antiparkinson Agents; D004149:Dioxoles; D010879:Piperazines; D011743:Pyrimidines; D007980:Levodopa; D001058:Apomorphine